Why Breast-Conserving Therapy Should be Considered Treatment of Choice in Early-Stage Breast Cancer Patients
- PMID: 34173138
- DOI: 10.1245/s10434-021-10203-x
Why Breast-Conserving Therapy Should be Considered Treatment of Choice in Early-Stage Breast Cancer Patients
References
-
- Van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17:1158–70. - DOI
-
- Tsoi B, Ziolkowski NI, Thoma A, Campbell K, O’Reilly D, Goeree R. Systematic review on the patient-reported outcomes of tissue-expander/implant vs autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients. J Am Coll Surg. 2014;218:1038–48. - DOI
-
- Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res. 2018;27:2077–86. - DOI
-
- Yoon AY, Bozzuto L, Seto AJ, Fisher CS, Chatterjee A. A systematic review of utility score assessments in the breast surgery cost-analysis literature. Ann Surg Oncol. 2019;26:1190–201. - DOI
-
- Kouwenberg CAE, de Ligt KM, Kranenburg LW, Rakhorst H, de Leeuw D, Siesling S, et al. Long-term health-related quality of life after four common surgical treatment options for breast cancer and the effect of complications: a retrospective patient-reported survey among 1871 patients. Plast Reconstr Surg. 2020;146:1–13. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical